GB0414797D0 - Compounds - Google Patents

Compounds

Info

Publication number
GB0414797D0
GB0414797D0 GBGB0414797.1A GB0414797A GB0414797D0 GB 0414797 D0 GB0414797 D0 GB 0414797D0 GB 0414797 A GB0414797 A GB 0414797A GB 0414797 D0 GB0414797 D0 GB 0414797D0
Authority
GB
United Kingdom
Prior art keywords
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0414797.1A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to GBGB0414797.1A priority Critical patent/GB0414797D0/en
Publication of GB0414797D0 publication Critical patent/GB0414797D0/en
Priority to PCT/EP2005/007136 priority patent/WO2006002956A1/en
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D211/62Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
GBGB0414797.1A 2004-07-01 2004-07-01 Compounds Ceased GB0414797D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0414797.1A GB0414797D0 (en) 2004-07-01 2004-07-01 Compounds
PCT/EP2005/007136 WO2006002956A1 (en) 2004-07-01 2005-06-29 Piperidine derivatives and their use as glycine transporter inhibitors

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0414797.1A GB0414797D0 (en) 2004-07-01 2004-07-01 Compounds

Publications (1)

Publication Number Publication Date
GB0414797D0 true GB0414797D0 (en) 2004-08-04

Family

ID=32843423

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0414797.1A Ceased GB0414797D0 (en) 2004-07-01 2004-07-01 Compounds

Country Status (2)

Country Link
GB (1) GB0414797D0 (en)
WO (1) WO2006002956A1 (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005058885A2 (en) * 2003-12-18 2005-06-30 Glaxo Group Limited Piperidine derivatives and their use as glycine transporter inhibitors

Also Published As

Publication number Publication date
WO2006002956A1 (en) 2006-01-12

Similar Documents

Publication Publication Date Title
GB0405933D0 (en) Compounds
EP1737831A4 (en) Neurologically-active compounds
GB0405937D0 (en) Compounds
EP1755617A4 (en) Perfluorocarbon-soluble compounds
GB0405193D0 (en) Compounds
GB0405272D0 (en) Compounds
GB0405267D0 (en) Compounds
GB0405101D0 (en) Compounds
GB0401269D0 (en) Compounds
GB0408772D0 (en) Compounds
GB0405280D0 (en) Compounds
GB0403593D0 (en) Compounds
GB0405893D0 (en) Compounds
GB0406916D0 (en) Compounds
GB0403595D0 (en) Compounds
GB0405198D0 (en) Compounds
GB0404083D0 (en) Compounds
GB0405270D0 (en) Compounds
GB0405774D0 (en) Compounds
GB0414797D0 (en) Compounds
GB0405263D0 (en) Compounds
GB0405248D0 (en) Compounds
GB0405230D0 (en) Compounds
GB0405899D0 (en) Compounds
GB0400695D0 (en) Compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)